<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35195253</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1470-8728</ISSN><JournalIssue CitedMedium="Internet"><Volume>479</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>17</Day></PubDate></JournalIssue><Title>The Biochemical journal</Title><ISOAbbreviation>Biochem J</ISOAbbreviation></Journal><ArticleTitle>A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.</ArticleTitle><Pagination><StartPage>537</StartPage><EndPage>559</EndPage><MedlinePgn>537-559</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1042/BCJ20220016</ELocationID><Abstract><AbstractText>Post-acute sequelae of COVID (PASC), usually referred to as 'Long COVID' (a phenotype of COVID-19), is a relatively frequent consequence of SARS-CoV-2 infection, in which symptoms such as breathlessness, fatigue, 'brain fog', tissue damage, inflammation, and coagulopathies (dysfunctions of the blood coagulation system) persist long after the initial infection. It bears similarities to other post-viral syndromes, and to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Many regulatory health bodies still do not recognize this syndrome as a separate disease entity, and refer to it under the broad terminology of 'COVID', although its demographics are quite different from those of acute COVID-19. A few years ago, we discovered that fibrinogen in blood can clot into an anomalous 'amyloid' form of fibrin that (like other &#x3b2;-rich amyloids and prions) is relatively resistant to proteolysis (fibrinolysis). The result, as is strongly manifested in platelet-poor plasma (PPP) of individuals with Long COVID, is extensive fibrin amyloid microclots that can persist, can entrap other proteins, and that may lead to the production of various autoantibodies. These microclots are more-or-less easily measured in PPP with the stain thioflavin T and a simple fluorescence microscope. Although the symptoms of Long COVID are multifarious, we here argue that the ability of these fibrin amyloid microclots (fibrinaloids) to block up capillaries, and thus to limit the passage of red blood cells and hence O2 exchange, can actually underpin the majority of these symptoms. Consistent with this, in a preliminary report, it has been shown that suitable and closely monitored 'triple' anticoagulant therapy that leads to the removal of the microclots also removes the other symptoms. Fibrin amyloid microclots represent a novel and potentially important target for both the understanding and treatment of Long COVID and related disorders.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0001-5838-7963</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZB, U.K.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Kemitorvet 200, 2800 Kgs Lyngby, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch Private Bag X1 Matieland, 7602, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laubscher</LastName><ForeName>Gert Jacobus</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Mediclinic Stellenbosch, Stellenbosch 7600, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9108-2384</Identifier><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch Private Bag X1 Matieland, 7602, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem J</MedlineTA><NlmUniqueID>2984726R</NlmUniqueID><ISSNLinking>0264-6021</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-31-4</RegistryNumber><NameOfSubstance UI="D005337">Fibrin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="Y">Amyloid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005337" MajorTopicYN="N">Fibrin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="Y">Lung</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">amyloid</Keyword><Keyword MajorTopicYN="N">clotting</Keyword></KeywordList><CoiStatement>E.P. is a named inventor on a patent application covering the use of fluorescence methods for microclot detection in Long COVID.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35195253</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pii">230829</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proal, A.D. and VanElzakker, M.B. (2021) Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue, J.K., Franko, N.M., McCulloch, D.J., McDonald, D., Magedson, A., Wolf, C.R.et al. (2021) Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 4, e210830 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M.V., McGroder, C., Stevens, J.S.et al. (2021) Post-acute COVID-19 syndrome. Nat. Med. 27, 601&#x2013;615 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya, A.A., Nemati, H., Shahisavandi, M., Akbari, A., Emami, A., Lotfi, M.et al. (2021) Long COVID in children and adolescents. World J. Pediatr. 17, 495&#x2013;499 10.1007/s12519-021-00457-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurdasani, D., Akrami, A., Bradley, V.C., Costello, A., Greenhalgh, T., Flaxman, S.et al. (2022) Long COVID in children. Lancet Child Adolesc. Health 6, e2 10.1016/S2352-4642(21)00342-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00342-4</ArticleId><ArticleId IdType="pmc">PMC8673872</ArticleId><ArticleId IdType="pubmed">34921807</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan, N.A. (2021) The road to addressing long COVID. Science 373, 491&#x2013;493 10.1126/science.abg7113</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg7113</ArticleId><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro, A., Bozzani, A., Tavazzi, G., Urtis, M., Giuliani, L., Pizzoccheri, R.et al. (2021) Long COVID: long-term effects? Eur. Heart J. Suppl. 23, E1&#x2013;E5 10.1093/eurheartj/suab080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab080</ArticleId><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall, M. (2021) The four most urgent questions about long COVID. Nature 594, 168&#x2013;170 10.1038/d41586-021-01511-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01511-z</ArticleId><ArticleId IdType="pubmed">34108700</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen, M., Manoharan, L., Elkheir, N., Cheng, V., Dagens, A., Hastie, C.et al. (2021) Characterising long COVID: a living systematic review. BMJ Glob. Health 6, e005427 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid, L., Drake, T.M., Pauley, E., Jesudason, E.C., Olliaro, P., Lim, W.S.et al. (2021) Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg. Health Eur. 8, 100186 10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H.E., Assaf, G.S., McCorkell, L., Wei, H., Low, R.J., Re'em, Y.et al. (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer, R.R., Rock, M.A., Vasilevsky, N., Carmody, L., Rando, H., Anzalone, A.J.et al. (2021) Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine 74, 103722 10.1016/j.ebiom.2021.103722</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe9;cary, S., Gaboury, I., Poirier, S., Garcia, C., Simpson, S., Bull, M.et al. (2021) Humility and acceptance: working within Our limits With long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. J. Orthop. Sports Phys. Ther. 51, 197&#x2013;200 10.2519/jospt.2021.0106</Citation><ArticleIdList><ArticleId IdType="doi">10.2519/jospt.2021.0106</ArticleId><ArticleId IdType="pubmed">33930983</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T., Knight, M., A'Court, C., Buxton, M. and Husain, L. (2020) Management of post-acute COVID-19 in primary care. BMJ 370, m3026 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Anfinsen, C.B. (1973) Principles that govern the folding of protein chains. Science 181, 223&#x2013;230 10.1126/science.181.4096.223</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.181.4096.223</ArticleId><ArticleId IdType="pubmed">4124164</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner, S.B. (1998) Prions. Proc. Natl Acad. Sci. U.S.A. 95, 13363&#x2013;13383 10.1073/pnas.95.23.13363</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.23.13363</ArticleId><ArticleId IdType="pmc">PMC33918</ArticleId><ArticleId IdType="pubmed">9811807</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral, P.K., Yin, J., Aguzzi, A. and James, M.N.G. (2019) Transition of the prion protein from a structured cellular form (PrP(C)) to the infectious scrapie agent (PrP(Sc)). Protein Sci. 28, 2055&#x2013;2063 10.1002/pro.3735</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3735</ArticleId><ArticleId IdType="pmc">PMC6863700</ArticleId><ArticleId IdType="pubmed">31583788</ArticleId></ArticleIdList></Reference><Reference><Citation>Tycko, R. (2016) Structure of aggregates revealed. Nature 537, 492&#x2013;493 10.1038/nature19470</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19470</ArticleId><ArticleId IdType="pmc">PMC5559282</ArticleId><ArticleId IdType="pubmed">27626376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke, P.C., Zhou, R., Serpell, L.C., Riek, R., Knowles, T.P.J., Lashuel, H.A.et al. (2020) Half a century of amyloids: past, present and future. Chem. Soc. Rev. 49, 5473&#x2013;5509 10.1039/C9CS00199A</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9CS00199A</ArticleId><ArticleId IdType="pmc">PMC7445747</ArticleId><ArticleId IdType="pubmed">32632432</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinge, J. (2016) Mammalian prions and their wider relevance in neurodegenerative diseases. Nature 539, 217&#x2013;226 10.1038/nature20415</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20415</ArticleId><ArticleId IdType="pubmed">27830781</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadanza, M.G., Jackson, M.P., Hewitt, E.W., Ranson, N.A. and Radford, S.E. (2018) A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell Biol. 19, 755&#x2013;773 10.1038/s41580-018-0060-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0060-8</ArticleId><ArticleId IdType="pubmed">30237470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick, A.W. and Saibil, H.R. (2019) Cryo-EM of amyloid fibrils and cellular aggregates. Curr. Opin. Struct. Biol. 58, 34&#x2013;42 10.1016/j.sbi.2019.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC6778506</ArticleId><ArticleId IdType="pubmed">31200186</ArticleId></ArticleIdList></Reference><Reference><Citation>Carta, M. and Aguzzi, A. (2021) Molecular foundations of prion strain diversity. Curr. Opin. Neurobiol. 72, 22&#x2013;31 10.1016/j.conb.2021.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2021.07.010</ArticleId><ArticleId IdType="pubmed">34416480</ArticleId></ArticleIdList></Reference><Reference><Citation>Blancas-Mej&#xed;a, L.M. and Ramirez-Alvarado, M. (2013) Systemic amyloidoses. Annu. Rev. Biochem. 82, 745&#x2013;774 10.1146/annurev-biochem-072611-130030</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-072611-130030</ArticleId><ArticleId IdType="pmc">PMC4044913</ArticleId><ArticleId IdType="pubmed">23451869</ArticleId></ArticleIdList></Reference><Reference><Citation>Palladini, G. and Merlini, G. (2013) Systemic amyloidoses: what an internist should know. Eur. J. Intern. Med. 24, 729&#x2013;739 10.1016/j.ejim.2013.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2013.10.007</ArticleId><ArticleId IdType="pubmed">24262289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2017) Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting. Progr. Biophys. Mol. Biol. 123, 16&#x2013;41 10.1016/j.pbiomolbio.2016.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2016.08.006</ArticleId><ArticleId IdType="pubmed">27554450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, K.J. and Yang, J. (2018) Translational opportunities for amyloid-targeting fluorophores. Chem. Commun (Camb) 54, 9107&#x2013;9118 10.1039/C8CC03619E</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8CC03619E</ArticleId><ArticleId IdType="pubmed">29993065</ArticleId></ArticleIdList></Reference><Reference><Citation>Apter, B., Lapshina, N., Barhom, H., Fainberg, B., Handelman, A., Accardo, A.et al. (2020) Fluorescence phenomena in amyloid and amyloidogenic bionanostructures. Crustals 10, 668 10.3390/cryst10080668</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cryst10080668</ArticleId></ArticleIdList></Reference><Reference><Citation>Howie, A.J. and Brewer, D.B. (2009) Optical properties of amyloid stained by Congo red: history and mechanisms. Micron 40, 285&#x2013;301 10.1016/j.micron.2008.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micron.2008.10.002</ArticleId><ArticleId IdType="pubmed">19019688</ArticleId></ArticleIdList></Reference><Reference><Citation>Peccati, F., Pantaleone, S., Riffet, V., Solans-Monfort, X., Contreras-Garcia, J., Guallar, V.et al. (2017) Binding of thioflavin T and related probes to polymorphic models of amyloid-beta fibrils. J. Phys. Chem. B 121, 8926&#x2013;8934 10.1021/acs.jpcb.7b06675</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.7b06675</ArticleId><ArticleId IdType="pubmed">28851223</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulatskaya, A.I., Kuznetsova, I.M. and Turoverov, K.K. (2012) Interaction of thioflavin T with amyloid fibrils: fluorescence quantum yield of bound dye. J. Phys. Chem. B 116, 2538&#x2013;2544 10.1021/jp2083055</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp2083055</ArticleId><ArticleId IdType="pubmed">22268449</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulatskaya, A.I., Rodina, N.P., Sulatsky, M.I., Povarova, O.I., Antifeeva, I.A., Kuznetsova, I.M.et al. (2018) Investigation of alpha-Synuclein amyloid fibrils using the fluorescent probe thioflavin T. Int. J. Mol. Sci. 19, 2486 10.3390/ijms19092486</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19092486</ArticleId><ArticleId IdType="pmc">PMC6163839</ArticleId><ArticleId IdType="pubmed">30142878</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurana, R., Coleman, C., Ionescu-Zanetti, C., Carter, S.A., Krishna, V., Grover, R.K.et al. (2005) Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 151, 229&#x2013;238 10.1016/j.jsb.2005.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2005.06.006</ArticleId><ArticleId IdType="pubmed">16125973</ArticleId></ArticleIdList></Reference><Reference><Citation>Amdursky, N., Erez, Y. and Huppert, D. (2012) Molecular rotors: what lies behind the high sensitivity of the thioflavin-T fluorescent marker. Acc. Chem. Res. 45, 1548&#x2013;1557 10.1021/ar300053p</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ar300053p</ArticleId><ArticleId IdType="pubmed">22738376</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancalana, M. and Koide, S. (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 1804, 1405&#x2013;1412 10.1016/j.bbapap.2010.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2010.04.001</ArticleId><ArticleId IdType="pmc">PMC2880406</ArticleId><ArticleId IdType="pubmed">20399286</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingstedt, T. and Nilsson, K.P.R. (2012) Luminescent conjugated poly- and oligo-thiophenes: optical ligands for spectral assignment of a plethora of protein aggregates. Biochem. Soc. Trans. 40, 704&#x2013;710 10.1042/BST20120009</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20120009</ArticleId><ArticleId IdType="pubmed">22817720</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal, G.M., Engelbrecht, L., Davis, T., de Villiers, W.J.S., Kell, D.B. and Pretorius, E. (2018) Correlative light-electron microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson's disease, Alzheimer's disease and type 2 diabetes mellitus. Sci. Rep. 8, 16798 10.1038/s41598-018-35009-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35009-y</ArticleId><ArticleId IdType="pmc">PMC6235901</ArticleId><ArticleId IdType="pubmed">30429533</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Page, M.J., Engelbrecht, L., Ellis, G.C. and Kell, D.B. (2017) Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains. Cardiovasc. Diabetol. 16, 141 10.1186/s12933-017-0624-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-017-0624-5</ArticleId><ArticleId IdType="pmc">PMC5668975</ArticleId><ArticleId IdType="pubmed">29096623</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskurt, O.K., Hardeman, M.R., Rampling, M.W. and Meiselman, H.J. (2007) Handbook of Hemorheology and Hemodynamics, IOS Press, Amsterdam</Citation></Reference><Reference><Citation>Cilia La Corte, A.L., Philippou, H. and and Ari&#xeb;ns, R.A.S. (2011) Role of fibrin structure in thrombosis and vascular disease. Adv. Protein Chem. Struct. Biol. 83, 75&#x2013;127 10.1016/B978-0-12-381262-9.00003-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-381262-9.00003-3</ArticleId><ArticleId IdType="pubmed">21570666</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinov, R.I., Pieters, M., de Lange-Loots, Z. and Weisel, J.W. (2021) Fibrinogen and fibrin. Subcell. Biochem. 96, 471&#x2013;501 10.1007/978-3-030-58971-4_15</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-58971-4_15</ArticleId><ArticleId IdType="pubmed">33252741</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel, J.W. and Litvinov, R.I. (2017) Fibrin formation, structure and properties. Subcell. Biochem. 82, 405&#x2013;456 10.1007/978-3-319-49674-0_13</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-49674-0_13</ArticleId><ArticleId IdType="pmc">PMC5536120</ArticleId><ArticleId IdType="pubmed">28101869</ArticleId></ArticleIdList></Reference><Reference><Citation>Undas, A. (2016) How to assess fibrinogen levels and fibrin clot properties in clinical practice? Semin. Thromb. Hemost. 42, 381&#x2013;388 10.1055/s-0036-1579636</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0036-1579636</ArticleId><ArticleId IdType="pubmed">27071050</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Briedenhann, S., Marx, J. and Franz, R.C. (2006) Structural changes in the fibrin network of a Pretoria family with dysfibrinogenemia: a scanning electron microscopical study. Ultrastruct. Pathol. 30, 167&#x2013;176 10.1080/01913120600689772</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120600689772</ArticleId><ArticleId IdType="pubmed">16825118</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. and Lipinski, B. (2013) Differences in morphology of fibrin clots induced with thrombin and ferric ions and its pathophysiological consequences. Heart Lung Circ. 22, 447&#x2013;449 10.1016/j.hlc.2012.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2012.10.010</ArticleId><ArticleId IdType="pubmed">23219312</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanepoel, A.C., Visagie, A., de Lange, Z., Emmerson, O., Nielsen, V.G. and Pretorius, E. (2016) The clinical relevance of altered fibrinogen packaging in the presence of 17beta-estradiol and progesterone. Thromb. Res. 146, 23&#x2013;34 10.1016/j.thromres.2016.08.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.08.022</ArticleId><ArticleId IdType="pubmed">27566845</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Mbotwe, S., Bester, J., Robinson, C.J. and Kell, D.B. (2016) Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide. J. R. Soc. Interface. 123, 20160539 10.1098/rsif.2016.0539</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2016.0539</ArticleId><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Page, M.J., Mbotwe, S. and Kell, D.B. (2018) Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease. PLoS ONE 13, e0192121 10.1371/journal.pone.0192121</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192121</ArticleId><ArticleId IdType="pmc">PMC5832207</ArticleId><ArticleId IdType="pubmed">29494603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Page, M.J., Hendricks, L., Nkosi, N.B., Benson, S.R. and Kell, D.B. (2018) Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel amytracker&#x2122; stains. J. R. Soc. Interface 15, 20170941 10.1098/rsif.2017.0941</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2017.0941</ArticleId><ArticleId IdType="pmc">PMC5832738</ArticleId><ArticleId IdType="pubmed">29445039</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Bester, J., Page, M.J. and Kell, D.B. (2018) The potential of LPS-binding protein to reverse amyloid formation in plasma fibrin of individuals with Alzheimer-type dementia. Front. Aging Neurosci. 10, 257 10.3389/fnagi.2018.00257</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00257</ArticleId><ArticleId IdType="pmc">PMC6113936</ArticleId><ArticleId IdType="pubmed">30186156</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankun, J., Landeta, P., Pretorius, E., Skrzypczak-Jankun, E. and Lipinski, B. (2014) Unusual clotting dynamics of plasma supplemented with iron(III). Int. J. Mol. Med. 33, 367&#x2013;372 10.3892/ijmm.2013.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2013.1585</ArticleId><ArticleId IdType="pubmed">24337469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2015) The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen). Integr. Biol. 7, 24&#x2013;52 10.1039/c4ib00173g</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4ib00173g</ArticleId><ArticleId IdType="pubmed">25335120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski, B., Pretorius, E., Oberholzer, H.M. and Van Der Spuy, W.J. (2012) Iron enhances generation of fibrin fibers in human blood: implications for pathogenesis of stroke. Microsc. Res. Tech. 75, 1185&#x2013;1190 10.1002/jemt.22047</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.22047</ArticleId><ArticleId IdType="pubmed">22488824</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Vermeulen, N., Bester, J. and Lipinski, B. (2013) Novel use of scanning electron microscopy for detection of iron-induced morphological changes in human blood. Microsc. Res. Tech. 76, 268&#x2013;271 10.1002/jemt.22163</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.22163</ArticleId><ArticleId IdType="pubmed">23280783</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Bester, J., Vermeulen, N., Lipinski, B., Gericke, G.S. and Kell, D.B. (2014) Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents. PLoS ONE 9, e85271 10.1371/journal.pone.0085271</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0085271</ArticleId><ArticleId IdType="pmc">PMC3887013</ArticleId><ArticleId IdType="pubmed">24416376</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. and Kell, D.B. (2014) Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr. Biol. 6, 486&#x2013;510 10.1039/C4IB00025K</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4IB00025K</ArticleId><ArticleId IdType="pubmed">24714688</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanepoel, A.C., Lindeque, B.G., Swart, P.J., Abdool, Z. and Pretorius, E. (2014) Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: a qualitative investigation. Microsc. Res. Tech. 77, 594&#x2013;601 10.1002/jemt.22378</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.22378</ArticleId><ArticleId IdType="pubmed">24841871</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M.J., Thomson, G.J.A., Nunes, J.M., Engelbrecht, A.M., Nell, T.A., de Villiers, W.J.S.et al. (2019) Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation. Sci. Rep. 9, 3102 10.1038/s41598-019-39056-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39056-x</ArticleId><ArticleId IdType="pmc">PMC6395759</ArticleId><ArticleId IdType="pubmed">30816210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bester, J., Soma, P., Kell, D.B. and Pretorius, E. (2015) Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS). Oncotarget Gerontol. 6, 35284&#x2013;35303 10.18632/oncotarget.6074</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6074</ArticleId><ArticleId IdType="pmc">PMC4742105</ArticleId><ArticleId IdType="pubmed">26462180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski, B. and Pretorius, E. (2013) The role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesium. Front. Hum. Neurosci. 7, 735 10.3389/fnhum.2013.00735</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2013.00735</ArticleId><ArticleId IdType="pmc">PMC3810650</ArticleId><ArticleId IdType="pubmed">24194714</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski, B. and Pretorius, W. (2014) Iron-induced fibrin formation may explain vascular pathology in Alzheimer's disease. Folia Neuropathol. 52, 205 10.5114/fn.2014.43792</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2014.43792</ArticleId><ArticleId IdType="pubmed">25118906</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Oberholzer, H.M., van der Spuy, W.J., Swanepoel, A.C. and Soma, P. (2011) Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes. Blood Coagul. Fibrinol. 22, 463&#x2013;467 10.1097/MBC.0b013e3283468a0d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e3283468a0d</ArticleId><ArticleId IdType="pubmed">21467917</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Bester, J., Vermeulen, N., Alummoottil, S., Soma, P., Buys, A.V.et al. (2015) Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics. Cardiovasc. Diabetol. 13, 30 10.1186/s12933-015-0192-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0192-5</ArticleId><ArticleId IdType="pmc">PMC4364097</ArticleId><ArticleId IdType="pubmed">25848817</ArticleId></ArticleIdList></Reference><Reference><Citation>Soma, P. and Pretorius, E. (2015) Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus. Cardiovasc. Diabetol. 14, 96 10.1186/s12933-015-0261-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0261-9</ArticleId><ArticleId IdType="pmc">PMC4521497</ArticleId><ArticleId IdType="pubmed">26228646</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezuidenhout, J., Venter, C., Roberts, T., Tarr, G., Kell, D. and Pretorius, E. (2020) The atypical fibrin fibre network in rheumatoid arthritis and its relation to autoimmunity, inflammation and thrombosis. bioRxiv 2020.05.28.121301v1 10.1101/2020.05.28.121301</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.28.121301</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezuidenhout, J., Venter, C., Roberts, T., Tarr, G., Kell, D. and Pretorius, E. (2020) Detection of citrullinated fibrin in plasma clots of RA patients and its relation to altered structural clot properties, disease-related inflammation and prothrombotic tendency. Front. Immunol. 11, 577523 10.3389/fimmu.2020.577523</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.577523</ArticleId><ArticleId IdType="pmc">PMC7793985</ArticleId><ArticleId IdType="pubmed">33424834</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Oberholzer, H.M., van der Spuy, W.J., Swanepoel, A.C. and Soma, P. (2012) Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis. Rheumatol. Int. 32, 1611&#x2013;1615 10.1007/s00296-011-1805-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-1805-2</ArticleId><ArticleId IdType="pubmed">21331577</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Akeredolu, O.-O., Soma, P. and Kell, D.B. (2017) Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp. Biol. Med. 242, 355&#x2013;373 10.1177/1535370216681549</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370216681549</ArticleId><ArticleId IdType="pmc">PMC5298544</ArticleId><ArticleId IdType="pubmed">27889698</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhimschi, I.A., Nayeri, U.A., Zhao, G., Shook, L.L., Pensalfini, A., Funai, E.F.et al. (2014) Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci. Transl. Med. 6, 245ra292 10.1126/scitranslmed.3008808</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3008808</ArticleId><ArticleId IdType="pubmed">25031267</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Kenny, L.C. (2016) A dormant microbial component in the development of pre-eclampsia. Front. Med. Obs. Gynecol. 3, 60 10.3389/fmed.2016.00060</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2016.00060</ArticleId><ArticleId IdType="pmc">PMC5126693</ArticleId><ArticleId IdType="pubmed">27965958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny, L.C. and Kell, D.B. (2018) Immunological tolerance, pregnancy and pre-eclampsia: the roles of semen microbes and the father. Front. Med. Obs. Gynecol. 4, 239 10.3389/fmed.2017.00239</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2017.00239</ArticleId><ArticleId IdType="pmc">PMC5758600</ArticleId><ArticleId IdType="pubmed">29354635</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinov, R.I., Faizullin, D.A., Zuev, Y.F. and Weisel, J.W. (2012) The alpha-helix to beta-sheet transition in stretched and compressed hydrated fibrin clots. Biophys. J. 103, 1020&#x2013;1027 10.1016/j.bpj.2012.07.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2012.07.046</ArticleId><ArticleId IdType="pmc">PMC3433599</ArticleId><ArticleId IdType="pubmed">23009851</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson, M.D., Liepnieks, J., Uemichi, T., Wheeler, G. and Correa, R. (1993) Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Nat. Genet. 3, 252&#x2013;255 10.1038/ng0393-252</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0393-252</ArticleId><ArticleId IdType="pubmed">8097946</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidinger, M., Werzowa, J., Kain, R., Antlanger, M., Hecking, M., Pfaffenberger, S.et al. (2013) Hereditary amyloidosis caused by R554L fibrinogen aalpha-chain mutation in a spanish family and review of the literature. Amyloid 20, 72&#x2013;79 10.3109/13506129.2013.781998</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13506129.2013.781998</ArticleId><ArticleId IdType="pubmed">23551149</ArticleId></ArticleIdList></Reference><Reference><Citation>Lendrum, A.C., Slidders, W. and Fraser, D.S. (1972) Renal hyalin. A study of amyloidosis and diabetic fibrinous vasculosis with new staining methods. J. Clin. Pathol. 25, 373&#x2013;396 10.1136/jcp.25.5.373</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.25.5.373</ArticleId><ArticleId IdType="pmc">PMC477332</ArticleId><ArticleId IdType="pubmed">4114696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kranenburg, O., Bouma, B., Kroon-Batenburg, L.M.J., Reijerkerk, A., Wu, Y.P., Voest, E.E.et al. (2002) Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. Curr. Biol. 12, 1833&#x2013;1839 10.1016/S0960-9822(02)01224-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(02)01224-1</ArticleId><ArticleId IdType="pubmed">12419183</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi, A. and Calella, A.M. (2009) Prions: protein aggregation and infectious diseases. Physiol. Rev. 89, 1105&#x2013;1152 10.1152/physrev.00006.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00006.2009</ArticleId><ArticleId IdType="pubmed">19789378</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva, C.J., Vazquez-Fern&#xe1;ndez, E., Onisko, B. and Requena, J.R. (2015) Proteinase K and the structure of PrPSc: the good, the bad and the ugly. Virus Res. 207, 120&#x2013;126 10.1016/j.virusres.2015.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.03.008</ArticleId><ArticleId IdType="pubmed">25816779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, F., Wang, X., Abskharon, R. and Ma, J. (2018) Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP(Sc). Acta Neuropathol. Commun. 6, 30 10.1186/s40478-018-0534-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0534-0</ArticleId><ArticleId IdType="pmc">PMC5921397</ArticleId><ArticleId IdType="pubmed">29699569</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick, A.W.P., Falcon, B., He, S., Murzin, A.G., Murshudov, G., Garringer, H.J.et al. (2017) Cryo-EM structures of tau filaments from Alzheimer's disease. Nature 547, 185&#x2013;190 10.1038/nature23002</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23002</ArticleId><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, D. and Liu, C. (2020) Structural diversity of amyloid fibrils and advances in their structure determination. Biochemistry 59, 639&#x2013;646 10.1021/acs.biochem.9b01069</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.9b01069</ArticleId><ArticleId IdType="pubmed">31967790</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavatelli, F., di Fonzo, A., Palladini, G. and Merlini, G. (2016) Systemic amyloidoses and proteomics: the state of the art. EuPA Open Proteom. 11, 4&#x2013;10 10.1016/j.euprot.2016.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euprot.2016.02.003</ArticleId><ArticleId IdType="pmc">PMC5988550</ArticleId><ArticleId IdType="pubmed">29900105</ArticleId></ArticleIdList></Reference><Reference><Citation>Linke, R.P. (2012) On typing amyloidosis using immunohistochemistry. Detailled illustrations, review and a note on mass spectrometry. Prog. Histochem. Cytochem. 47, 61&#x2013;132 10.1016/j.proghi.2012.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.proghi.2012.03.001</ArticleId><ArticleId IdType="pubmed">22819384</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul, D.J., Unda, S.R., de La Garza Ramos, R., Zampolin, R., Benton, J., Holland, R.et al. (2020) Hemorrhagic presentations of COVID-19: risk factors for mortality. Clin. Neurol. Neurosurg. 198, 106112 10.1016/j.clineuro.2020.106112</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.106112</ArticleId><ArticleId IdType="pmc">PMC7382923</ArticleId><ArticleId IdType="pubmed">32738585</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler, C., Maphumulo, S.C., Grobbelaar, L.M., Bredenkamp, J., Laubscher, J., Lourens, P.J.et al. (2020) COVID-19: the rollercoaster of fibrin(ogen), D-dimer, von willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes. Int. J. Mol. Sci. 21, 5168 10.3390/ijms21145168</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145168</ArticleId><ArticleId IdType="pmc">PMC7403995</ArticleId><ArticleId IdType="pubmed">32708334</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba, T., Levy, J.H., Levi, M. and Thachil, J. (2020) Coagulopathy in COVID-19. J. Thromb. Haemost. 18, 2103&#x2013;2109 10.1111/jth.14975</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14975</ArticleId><ArticleId IdType="pmc">PMC7323352</ArticleId><ArticleId IdType="pubmed">32558075</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok, F.A., Kruip, M., van der Meer, N.J.M., Arbous, M.S., Gommers, D., Kant, K.M.et al. (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb. Res. 191, 148&#x2013;150 10.1016/j.thromres.2020.04.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7192101</ArticleId><ArticleId IdType="pubmed">32381264</ArticleId></ArticleIdList></Reference><Reference><Citation>Malas, M.B., Naazie, I.N., Elsayed, N., Mathlouthi, A., Marmor, R. and Clary, B. (2020) Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine 29, 100639 10.1016/j.eclinm.2020.100639</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100639</ArticleId><ArticleId IdType="pmc">PMC7679115</ArticleId><ArticleId IdType="pubmed">33251499</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M.et al. (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. 18, 1023&#x2013;1026 10.1111/jth.14810</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14810</ArticleId><ArticleId IdType="pmc">PMC9906133</ArticleId><ArticleId IdType="pubmed">32338827</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Mesa, J.E., Galindo-Coral, S., Montes, M.C. and Mu&#xf1;oz Martin, A.J. (2021) Thrombosis and coagulopathy in COVID-19. Curr. Probl. Cardiol. 46, 100742 10.1016/j.cpcardiol.2020.100742</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100742</ArticleId><ArticleId IdType="pmc">PMC7605852</ArticleId><ArticleId IdType="pubmed">33243440</ArticleId></ArticleIdList></Reference><Reference><Citation>Leentjens, J., van Haaps, T.F., Wessels, P.F., Schutgens, R.E.G. and Middeldorp, S. (2021) COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year. Lancet Haematol. 8, e524&#x2013;e533 10.1016/S2352-3026(21)00105-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(21)00105-8</ArticleId><ArticleId IdType="pmc">PMC8078884</ArticleId><ArticleId IdType="pubmed">33930350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorini, F.L., Di Matteo, M., Gritti, P., Grazioli, L., Benigni, A., Zacchetti, L.et al. (2021) Coagulopathy and COVID-19. Eur. Heart J. Suppl. 23, E95&#x2013;E98 10.1093/eurheartj/suab100</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab100</ArticleId><ArticleId IdType="pmc">PMC8503535</ArticleId><ArticleId IdType="pubmed">34650364</ArticleId></ArticleIdList></Reference><Reference><Citation>Polimeni, A., Leo, I., Spaccarotella, C., Mongiardo, A., Sorrentino, S., Sabatino, J.et al. (2021) Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients. Sci. Rep. 11, 10464 10.1038/s41598-021-89967-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89967-x</ArticleId><ArticleId IdType="pmc">PMC8128869</ArticleId><ArticleId IdType="pubmed">34001992</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar, M., Madabhavi, I.V., Quy, P.N. and Govindagoudar, M.B. (2021) COVID-19 and coagulopathy. Clin. Respir. J. 15, 1259&#x2013;1274 10.1111/crj.13438</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/crj.13438</ArticleId><ArticleId IdType="pmc">PMC8444678</ArticleId><ArticleId IdType="pubmed">34399021</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, J.L., Levi, M. and Hunt, B.J. (2021) Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia. Lancet Respir. Med. 10, 214&#x2013;220 10.1016/S2213-2600(21)00455-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00455-0</ArticleId><ArticleId IdType="pmc">PMC8616572</ArticleId><ArticleId IdType="pubmed">34838161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Paz, L., Capodanno, D., Montalescot, G. and Angiolillo, D.J. (2021) Coronavirus disease 2019-associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management. J. Am Heart Assoc. 10, e019650. 10.1161/JAHA.120.019650</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.019650</ArticleId><ArticleId IdType="pmc">PMC7955431</ArticleId><ArticleId IdType="pubmed">33228447</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Z., Gao, X., Miao, H., Ma, X. and Ding, R. (2021) Understanding COVID-19-associated coagulopathy: from PIC to SIC or DIC. J Intens. Med. 1, 35&#x2013;41 10.1016/j.jointm.2021.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jointm.2021.03.002</ArticleId><ArticleId IdType="pmc">PMC7997848</ArticleId><ArticleId IdType="pubmed">36943814</ArticleId></ArticleIdList></Reference><Reference><Citation>Douillet, D., Riou, J., Penaloza, A., Moumneh, T., Soulie, C., Savary, D.et al. (2021) Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: a comparison of two prospective European cohorts. Thromb. Res. 208, 4&#x2013;10 10.1016/j.thromres.2021.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.10.001</ArticleId><ArticleId IdType="pmc">PMC8498792</ArticleId><ArticleId IdType="pubmed">34653718</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi, M. and Thachil, J. (2020) Coronavirus disease 2019 coagulopathy: disseminated intravascular coagulation and thrombotic microangiopathy-Either, neither, or both. Semin. Thromb. Hemost. 46, 781&#x2013;784 10.1055/s-0040-1712156</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1712156</ArticleId><ArticleId IdType="pmc">PMC7645819</ArticleId><ArticleId IdType="pubmed">32512589</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil, J. (2021) Lessons learnt from COVID-19 coagulopathy. EJHaem 2, 577&#x2013;584 10.1002/jha2.228</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jha2.228</ArticleId><ArticleId IdType="pmc">PMC8242569</ArticleId><ArticleId IdType="pubmed">34226900</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter, C., Bezuidenhout, J.A., Laubscher, G.J., Lourens, P.J., Steenkamp, J., Kell, D.B.et al. (2020) Erythrocyte, platelet, serum ferritin and P-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int. J. Mol. Sci. 21, 8234 10.3390/ijms21218234</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218234</ArticleId><ArticleId IdType="pmc">PMC7662625</ArticleId><ArticleId IdType="pubmed">33153161</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty, H., Townsend, L., Ni Cheallaigh, C., Bergin, C., Martin-Loeches, I., Browne, P.et al. (2020) COVID19 coagulopathy in Caucasian patients. Br. J. Haematol. 189, 1044&#x2013;1049 10.1111/bjh.16749</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16749</ArticleId><ArticleId IdType="pmc">PMC7264579</ArticleId><ArticleId IdType="pubmed">32330308</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray, M.A., Sartain, S.E., Gollamudi, J. and Rumbaut, R.E. (2020) Microvascular thrombosis: experimental and clinical implications. Transl. Res. 225, 105&#x2013;130 10.1016/j.trsl.2020.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7245314</ArticleId><ArticleId IdType="pubmed">32454092</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi, M., Thachil, J., Iba, T. and Levy, J.H. (2020) Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 7, e438&#x2013;e440 10.1016/S2352-3026(20)30145-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Willyard, C. (2020) Coronavirus blood-clot mystery intensifies. Nature 581, 250 10.1038/d41586-020-01403-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-01403-8</ArticleId><ArticleId IdType="pubmed">32393875</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Venter, C., Laubscher, G.J., Lourens, P.J., Steenkamp, J. and Kell, D.B. (2020) Prevalence of amyloid blood clots in COVID-19 plasma. medRxiv 10.1101/2020.07.28.20163543</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.28.20163543</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakura, H. and Ogawa, H. (2021) COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int. J. Hematol. 113, 45&#x2013;57 10.1007/s12185-020-03029-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-020-03029-y</ArticleId><ArticleId IdType="pmc">PMC7648664</ArticleId><ArticleId IdType="pubmed">33161508</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar, L.M., Venter, C., Vlok, M., Ngoepe, M., Laubscher, G.J., Lourens, P.J.et al. (2021) SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep. 41, BSR20210611 10.1042/BSR20210611</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubscher, G.J., Lourens, P.J., Venter, C., Kell, D.B. and Pretorius, E. (2021) TEG&#xae;, microclot and platelet mapping for guiding early management of severe COVID-19 coagulopathy. J. Clin. Med. 10, 5381 10.3390/jcm10225381</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225381</ArticleId><ArticleId IdType="pmc">PMC8621180</ArticleId><ArticleId IdType="pubmed">34830660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wygrecka, M., Birnhuber, A., Seeliger, B., Michalick, L., Pak, O., Schultz, A.S.et al. (2021) Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. Blood Adv. 6, 1074&#x2013;1087 10.1182/bloodadvances.2021004816</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021004816</ArticleId><ArticleId IdType="pmc">PMC8648369</ArticleId><ArticleId IdType="pubmed">34861681</ArticleId></ArticleIdList></Reference><Reference><Citation>Wool, G.D. and Miller, J.L. (2021) The impact of COVID-19 disease on platelets and coagulation. Pathobiology 88, 15&#x2013;27 10.1159/000512007</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512007</ArticleId><ArticleId IdType="pmc">PMC7649697</ArticleId><ArticleId IdType="pubmed">33049751</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba, T., Levy, J.H., Connors, J.M., Warkentin, T.E., Thachil, J. and Levi, M. (2020) The unique characteristics of COVID-19 coagulopathy. Crit. Care 24, 360 10.1186/s13054-020-03077-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03077-0</ArticleId><ArticleId IdType="pmc">PMC7301352</ArticleId><ArticleId IdType="pubmed">32552865</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo, J., Spittle, D.A. and Newnham, M. (2021) COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 76, 412&#x2013;420 10.1136/thoraxjnl-2020-216243</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216243</ArticleId><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolis, A.S., Manolis, T.A., Manolis, A.A., Papatheou, D. and Melita, H. (2021) COVID-19 Infection: viral macro- and micro-Vascular coagulopathy and thromboembolism/Prophylactic and therapeutic management. J. Cardiovasc. Pharmacol. Ther. 26, 12&#x2013;24 10.1177/1074248420958973</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248420958973</ArticleId><ArticleId IdType="pmc">PMC7492826</ArticleId><ArticleId IdType="pubmed">32924567</ArticleId></ArticleIdList></Reference><Reference><Citation>Poor, H.D. (2021) Pulmonary thrombosis and thromboembolism in COVID-19. Chest 160, 1471&#x2013;1480 10.1016/j.chest.2021.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.06.016</ArticleId><ArticleId IdType="pmc">PMC8213519</ArticleId><ArticleId IdType="pubmed">34153340</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Vlok, M., Venter, C., Bezuidenhout, J.A., Laubscher, G.J., Steenkamp, J.et al. (2021) Persistent clotting protein pathology in long COVID/ post-Acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 20, 172 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin, M., Engelen, M.M., Barco, S., Spyropoulos, A.C., Vanassche, T., Hunt, B.J.et al. (2021) Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: a systematic review and meta-analysis. Thromb. Res. 209, 94&#x2013;98 10.1016/j.thromres.2021.11.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.11.029</ArticleId><ArticleId IdType="pmc">PMC8648604</ArticleId><ArticleId IdType="pubmed">34896917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, J.K., Sozmen, E.G.. Dixit, K., Montano, M., Matsui, Y., Liu, Y.et al. (2021) SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. bioRxiv 2021.10.12.464152 10.1101/2021.10.12.464152</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.12.464152</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfella, R., Paolisso, P., Sardu, C., Palomba, L., D'Onofrio, N., Cesaro, A.et al. (2021) SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. Crit. Care 25, 217 10.1186/s13054-021-03643-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03643-0</ArticleId><ArticleId IdType="pmc">PMC8222703</ArticleId><ArticleId IdType="pubmed">34167575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jana, A.K., Greenwood, A.B. and Hansmann, U.H.E. (2021) Presence of a SARS-CoV-2 protein enhances amyloid formation of serum amyloid A. J. Phys. Chem. B 125, 9155&#x2013;9167 10.1021/acs.jpcb.1c04871</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.1c04871</ArticleId><ArticleId IdType="pmc">PMC8369982</ArticleId><ArticleId IdType="pubmed">34370466</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki, R.F., Lathe, R., Balin, B.J., Ball, M.J., Braak, H., Bearer, E.L.et al. (2016) Microbes and Alzheimer's disease. J. Alzheimers Dis. 51, 979&#x2013;984 10.3233/JAD-160152</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160152</ArticleId><ArticleId IdType="pmc">PMC5457904</ArticleId><ArticleId IdType="pubmed">26967229</ArticleId></ArticleIdList></Reference><Reference><Citation>Brothers, H.M., Gosztyla, M.L. and Robinson, S.R. (2018) The physiological roles of amyloid-beta peptide hint at New ways to treat Alzheimer's disease. Front. Aging Neurosci. 10, 118 10.3389/fnagi.2018.00118</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00118</ArticleId><ArticleId IdType="pmc">PMC5996906</ArticleId><ArticleId IdType="pubmed">29922148</ArticleId></ArticleIdList></Reference><Reference><Citation>Eimer, W.A., Vijaya Kumar, D.K., Navalpur Shanmugam, N.K., Rodriguez, A.S., Mitchell, T., Washicosky, K.J.et al. (2018) Alzheimer's disease-Associated beta-Amyloid Is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99, 56&#x2013;63.e53 10.1016/j.neuron.2018.06.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.06.030</ArticleId><ArticleId IdType="pmc">PMC6075814</ArticleId><ArticleId IdType="pubmed">30001512</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolotti, D., Gentili, V., Rotola, A., Caselli, E. and Rizzo, R. (2019) HHV-6A infection induces amyloid-beta expression and activation of microglial cells. Alzheimers Res. Ther. 11, 104 10.1186/s13195-019-0552-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0552-6</ArticleId><ArticleId IdType="pmc">PMC6909659</ArticleId><ArticleId IdType="pubmed">31831060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sait, A., Angeli, C., Doig, A.J. and Day, P.J.R. (2021) Viral involvement in Alzheimer's disease. ACS Chem. Neurosci. 12, 1049&#x2013;1060 10.1021/acschemneuro.0c00719</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00719</ArticleId><ArticleId IdType="pmc">PMC8033564</ArticleId><ArticleId IdType="pubmed">33687205</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansell, D.M., Goldin, J.G., King, Jr, T.E., Lynch, D.A., Richeldi, L. and Wells, A.U. (2015) CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the fleischner society. Lancet Respir. Med. 3, 483&#x2013;496 10.1016/S2213-2600(15)00096-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00096-X</ArticleId><ArticleId IdType="pubmed">25975761</ArticleId></ArticleIdList></Reference><Reference><Citation>Parekh, M., Donuru, A., Balasubramanya, R. and Kapur, S. (2020) Review of the chest CT differential diagnosis of ground-Glass opacities in the COVID Era. Radiology 297, E289&#x2013;E302 10.1148/radiol.2020202504</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202504</ArticleId><ArticleId IdType="pmc">PMC7350036</ArticleId><ArticleId IdType="pubmed">32633678</ArticleId></ArticleIdList></Reference><Reference><Citation>Warman, A., Warman, P., Sharma, A., Parikh, P., Warman, R., Viswanadhan, N.et al. (2020) Interpretable artificial intelligence for COVID-19 diagnosis from chest CT reveals specificity of ground-Glass opacities. medRxiv 10.1101/2020.05.16.20103408</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.16.20103408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, W., Zhong, Z., Xie, X., Yu, Q. and Liu, J. (2020) Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am. J. Roentgenol. 214, 1072&#x2013;1077 10.2214/AJR.20.22976</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.20.22976</ArticleId><ArticleId IdType="pubmed">32125873</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzi, D., Cavigli, E., Moroni, C., Smorchkova, O., Zantonelli, G., Pradella, S.et al. (2021) Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J. Radiol. 39, 721&#x2013;732 10.1007/s11604-021-01120-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11604-021-01120-w</ArticleId><ArticleId IdType="pmc">PMC8071755</ArticleId><ArticleId IdType="pubmed">33900542</ArticleId></ArticleIdList></Reference><Reference><Citation>Roig-Mar&#xed;n, N. and Roig-Rico, P. (2021) Ground-glass opacity on emergency department chest X-ray: a risk factor for in-hospital mortality and organ failure in elderly admitted for COVID-19. Postgrad. Med. 10.1080/00325481.2021.2021741</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2021.2021741</ArticleId><ArticleId IdType="pubmed">34930067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, D., Shang, Y., Chen, Y., Xia, J., Tian, W., Zhang, T.et al. (2021) Clinical value of COVID-19 chest radiography and high-resolution CT examination. Curr. Med. Imaging 10.2174/1573405618666211229143121</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573405618666211229143121</ArticleId><ArticleId IdType="pubmed">34967290</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickford, H.A., Swensen, S.J. and Utz, J.P. (1997) Thoracic cross-sectional imaging of amyloidosis. AJR Am. J. Roentgenol. 168, 351&#x2013;355 10.2214/ajr.168.2.9016204</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/ajr.168.2.9016204</ArticleId><ArticleId IdType="pubmed">9016204</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani, P., Basset, M., Russo, F., Foli, A., Palladini, G. and Merlini, G. (2017) The lung in amyloidosis. Eur. Respir. Rev. 26, 170046 10.1183/16000617.0046-2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0046-2017</ArticleId><ArticleId IdType="pmc">PMC9488920</ArticleId><ArticleId IdType="pubmed">28877975</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Jin, Z., Zhang, H., Zhang, Y., Shi, M., Meng, F.et al. (2018) Diffuse parenchymal pulmonary amyloidosis associated with multiple myeloma: a case report and systematic review of the literature. BMC Cancer 18, 802 10.1186/s12885-018-4565-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-018-4565-5</ArticleId><ArticleId IdType="pmc">PMC6083508</ArticleId><ArticleId IdType="pubmed">30089469</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgart, J.V., Stuhlmann-Laeisz, C., Hegenbart, U., Nattenm&#xfc;ller, J., Sch&#xf6;nland, S., Kr&#xfc;ger, S.et al. (2018) Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical management. Virchows. Arch. 473, 627&#x2013;637 10.1007/s00428-018-2442-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-018-2442-x</ArticleId><ArticleId IdType="pubmed">30136180</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson, J., Debray, M.P., Boussouar, S., Khalil, A., Bancal, C., Motiejunaite, J.et al. (2021) Residual ground glass opacities three months after COVID-19 pneumonia correlate to alteration of respiratory function: the post COVID M3 study. Respir. Med. 184, 106435 10.1016/j.rmed.2021.106435</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106435</ArticleId><ArticleId IdType="pmc">PMC8123365</ArticleId><ArticleId IdType="pubmed">34020126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, X.L. and Sadler, J.E. (2008) Pathogenesis of thrombotic microangiopathies. Annu. Rev. Pathol. 3, 249&#x2013;277 10.1146/annurev.pathmechdis.3.121806.154311</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.154311</ArticleId><ArticleId IdType="pmc">PMC2582586</ArticleId><ArticleId IdType="pubmed">18215115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes da Silva, R. (2011) Viral-associated thrombotic microangiopathies. Hematol. Oncol. Stem Cell Ther. 4, 51&#x2013;59 10.5144/1658-3876.2011.51</Citation><ArticleIdList><ArticleId IdType="doi">10.5144/1658-3876.2011.51</ArticleId><ArticleId IdType="pubmed">21727765</ArticleId></ArticleIdList></Reference><Reference><Citation>Bommer, M., Wolfle-Guter, M., Bohl, S. and Kuchenbauer, F. (2018) The differential diagnosis and treatment of thrombotic microangiopathies. Dtsch. Arztebl. Int. 115, 327&#x2013;334 10.3238/arztebl.2018.0327</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2018.0327</ArticleId><ArticleId IdType="pmc">PMC5997890</ArticleId><ArticleId IdType="pubmed">29875054</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakhouri, F. (2016) Pregnancy-related thrombotic microangiopathies: clues from complement biology. Transfus. Apher. Sci. 54, 199&#x2013;202 10.1016/j.transci.2016.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2016.04.009</ArticleId><ArticleId IdType="pubmed">27158062</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosove, M.H. (2014) Thrombotic microangiopathies. Semin. Arthritis Rheum. 43, 797&#x2013;805 10.1016/j.semarthrit.2013.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2013.11.004</ArticleId><ArticleId IdType="pubmed">24360024</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson, K., Simon, R., Sj&#xf6;lander, D., Sigurdson, C.J., Hammarstr&#xf6;m, P. and Nilsson, K.P.R. (2014) Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands. Prion 8, 319&#x2013;329 10.4161/pri.29239</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.29239</ArticleId><ArticleId IdType="pmc">PMC4601348</ArticleId><ArticleId IdType="pubmed">25495506</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson, K., Appelqvist, H., Cieslar-Pobuda, A., Back, M., K&#xe5;gedal, B., Jonasson, J.A.et al. (2015) An imidazole functionalized pentameric thiophene displays different staining patterns in normal and malignant cells. Front. Chem. 3, 58 10.3389/fchem.2015.00058</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2015.00058</ArticleId><ArticleId IdType="pmc">PMC4595803</ArticleId><ArticleId IdType="pubmed">26501054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegenast-Braun, B.M., Skodras, A., Bayraktar, G., Mahler, J., Fritschi, S.K., Klingstedt, T.et al. (2012) Spectral discrimination of cerebral amyloid lesions after peripheral application of luminescent conjugated oligothiophenes. Am. J. Pathol. 181, 1953&#x2013;1960 10.1016/j.ajpath.2012.08.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2012.08.031</ArticleId><ArticleId IdType="pubmed">23041059</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;z, M.E., Balci, A. and Menek&#x15f;e, E. (2020) D-dimer levels and COVID-19 severity: systematic review and meta-Analysis. Tuberk. Toraks. 68, 353&#x2013;360 10.5578/tt.70351</Citation><ArticleIdList><ArticleId IdType="doi">10.5578/tt.70351</ArticleId><ArticleId IdType="pubmed">33448732</ArticleId></ArticleIdList></Reference><Reference><Citation>Favaloro, E.J. and Thachil, J. (2020) Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation. Clin. Chem. Lab. Med. 58, 1191&#x2013;1199 10.1515/cclm-2020-0573</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0573</ArticleId><ArticleId IdType="pubmed">32432563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber, G.F. and Chaturvedi, S. (2021) How to recognize and manage COVID-19-associated coagulopathy. Hematol. Am. Soc. Hematol. Educ. Program 2021, 614&#x2013;620 10.1182/hematology.2021000297</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/hematology.2021000297</ArticleId><ArticleId IdType="pmc">PMC8791093</ArticleId><ArticleId IdType="pubmed">34889412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrdad, R., Zahra, K. and Mansouritorghabeh, H. (2021) Hemostatic system (Fibrinogen level, D-Dimer, and FDP) in severe and Non-Severe patients With COVID-19: a systematic review and meta-Analysis. Clin. Appl. Thromb. Hemost. 27, 10760296211010973 10.1177/10760296211010973</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296211010973</ArticleId><ArticleId IdType="pmc">PMC8728788</ArticleId><ArticleId IdType="pubmed">34933579</ArticleId></ArticleIdList></Reference><Reference><Citation>Paliogiannis, P., Mangoni, A.A., Dettori, P., Nasrallah, G.K., Pintus, G. and Zinellu, A. (2020) D-Dimer concentrations and COVID-19 severity: a systematic review and meta-Analysis. Front. Public Health 8, 432 10.3389/fpubh.2020.00432</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00432</ArticleId><ArticleId IdType="pmc">PMC7438945</ArticleId><ArticleId IdType="pubmed">32903841</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel, A., Poudel, Y., Adhikari, A., Aryal, B.B., Dangol, D., Bajracharya, T.et al. (2021) D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS ONE 16, e0256744 10.1371/journal.pone.0256744</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256744</ArticleId><ArticleId IdType="pmc">PMC8389366</ArticleId><ArticleId IdType="pubmed">34437642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami, M. and Mansouritorghabeh, H. (2020) D-dimer level in COVID-19 infection: a systematic review. Expert Rev. Hematol. 13, 1265&#x2013;1275 10.1080/17474086.2020.1831383</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17474086.2020.1831383</ArticleId><ArticleId IdType="pubmed">32997543</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, S., Shah, K., Patel, S.B., Patel, F.S., Osman, M., Velagapudi, P.et al. (2020) Elevated D-Dimer levels are associated with increased risk of mortality in COVID-19: a systematic review and meta-Analysis. Cardiol. Rev. 28, 295&#x2013;302 10.1097/CRD.0000000000000330</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000330</ArticleId><ArticleId IdType="pmc">PMC7437424</ArticleId><ArticleId IdType="pubmed">33017364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Q., Cheng, J., Shang, J., Wang, Y., Wan, J., Yan, Y.Q.et al. (2021) Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study. BMJ Open 11, e043790 10.1136/bmjopen-2020-043790</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043790</ArticleId><ArticleId IdType="pmc">PMC8488281</ArticleId><ArticleId IdType="pubmed">34598979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupferschmidt, K. (2021) Startling new variant raises urgent questions. Science 374, 1178&#x2013;1180 10.1126/science.acx9737</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.acx9737</ArticleId><ArticleId IdType="pubmed">34855503</ArticleId></ArticleIdList></Reference><Reference><Citation>Currin, A., Swainston, N., Day, P.J. and Kell, D.B. (2015) Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently. Chem. Soc. Rev. 44, 1172&#x2013;1239 10.1039/C4CS00351A</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4CS00351A</ArticleId><ArticleId IdType="pmc">PMC4349129</ArticleId><ArticleId IdType="pubmed">25503938</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend, L., Fogarty, H., Dyer, A., Martin-Loeches, I., Bannan, C., Nadarajan, P.et al. (2021) Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J. Thromb. Haemost. 19, 1064&#x2013;1070 10.1111/jth.15267</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry, D.J. (2021) A pratial guide to haemostasis</Citation></Reference><Reference><Citation>Weil, I.A., Seicean, S., Neuhauser, D., Schiltz, N.K. and Seicean, A. (2015) Use and utility of hemostatic screening in adults undergoing elective, non-cardiac surgery. PLoS ONE 10, e0139139 10.1371/journal.pone.0139139</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0139139</ArticleId><ArticleId IdType="pmc">PMC4666643</ArticleId><ArticleId IdType="pubmed">26623648</ArticleId></ArticleIdList></Reference><Reference><Citation>Loizou, E., Mayhew, D.J., Martlew, V. and Murthy, B.V.S. (2018) Implications of deranged activated partial thromboplastin time for anaesthesia and surgery. Anaesthesia 73, 1557&#x2013;1563 10.1111/anae.14344</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14344</ArticleId><ArticleId IdType="pubmed">30315725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitlur, M., Sorensen, B., Rivard, G.E., Young, G., Ingerslev, J., Othman, M.et al. (2011) Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia 17, 532&#x2013;537 10.1111/j.1365-2516.2010.02451.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2516.2010.02451.x</ArticleId><ArticleId IdType="pubmed">21323795</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen, V.G. and Pretorius, E. (2014) Iron-enhanced coagulation is attenuated by chelation: thrombelastographic and ultrastructural analysis. Blood Coagul. Fibrinol. 25, 845&#x2013;850 10.1097/MBC.0000000000000160</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000160</ArticleId><ArticleId IdType="pubmed">24991945</ArticleId></ArticleIdList></Reference><Reference><Citation>de Villiers, S., Bester, J., Kell, D.B. and Pretorius, E. (2019) Erythrocyte health and the possible role of amyloidogenic blood clotting in the evolving haemodynamics of female migraine-with-aura pathophysiology: results from a pilot study. Front. Neurol. 10, 1262 10.3389/fneur.2019.01262</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01262</ArticleId><ArticleId IdType="pmc">PMC6887655</ArticleId><ArticleId IdType="pubmed">31849822</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2015) On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr. Biol. 7, 1339&#x2013;1377 10.1039/c5ib00158g</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c5ib00158g</ArticleId><ArticleId IdType="pubmed">26345428</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdoes, G., Schloer, H., Eberle, B. and Nagler, M. (2018) Next generation viscoelasticity assays in cardiothoracic surgery: feasibility of the TEG6s system. PLoS ONE 13, e0209360 10.1371/journal.pone.0209360</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0209360</ArticleId><ArticleId IdType="pmc">PMC6301661</ArticleId><ArticleId IdType="pubmed">30571781</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Luz, L.T., Nascimento, B., Shankarakutty, A.K., Rizoli, S. and Adhikari, N.K. (2014) Effect of thromboelastography (TEG(R)) and rotational thromboelastometry (ROTEM(R)) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit. Care 18, 518 10.1186/s13054-014-0518-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0518-9</ArticleId><ArticleId IdType="pmc">PMC4206701</ArticleId><ArticleId IdType="pubmed">25261079</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz, R.C. (2009) ROTEM analysis: a significant advance in the field of rotational thrombelastography. S. Afr. J. Surg. 47, 2&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">19405329</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson, G.N.B., Ashpole, K.J. and Yentis, S.M. (2009) The TEG((R)) vs the ROTEM((R)) thromboelastography/thromboelastometry systems. Anaesthesia 64, 212&#x2013;215 10.1111/j.1365-2044.2008.05752.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2008.05752.x</ArticleId><ArticleId IdType="pubmed">19143701</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, T., Bauters, A., Braun, S.L., Potzsch, B., von Pape, K.W., Kolde, H.J.et al. (2005) Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul. Fibrinol. 16, 301&#x2013;310 10.1097/01.mbc.0000169225.31173.19</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mbc.0000169225.31173.19</ArticleId><ArticleId IdType="pubmed">15870552</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen, V.G. (2007) A comparison of the Thrombelastograph and the ROTEM. Blood Coagul. Fibrinol. 18, 247&#x2013;252 10.1097/MBC.0b013e328092ee05</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e328092ee05</ArticleId><ArticleId IdType="pubmed">17413761</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka, K.A., Bolliger, D., Vadlamudi, R. and Nimmo, A. (2012) Rotational thromboelastometry (ROTEM)-based coagulation management in cardiac surgery and major trauma. J. Cardiothorac. Vasc. Anesth. 26, 1083&#x2013;1093 10.1053/j.jvca.2012.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.06.015</ArticleId><ArticleId IdType="pubmed">22863406</ArticleId></ArticleIdList></Reference><Reference><Citation>Theusinger, O.M., Schroder, C.M., Eismon, J., Emmert, M.Y., Seifert, B., Spahn, D.R.et al. (2013) The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage. Anesth. Analg. 117, 314&#x2013;321 10.1213/ANE.0b013e31829569ac</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31829569ac</ArticleId><ArticleId IdType="pubmed">23780419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikkels&#xf8;, A., Wetterslev, J., M&#xf8;ller, A.M. and Afshari, A. (2016) Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst. Rev. 2016, CD007871 10.1002/14651858.CD007871.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007871.pub3</ArticleId><ArticleId IdType="pmc">PMC6472507</ArticleId><ArticleId IdType="pubmed">27552162</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, J.F., Knowles, T.P., Dobson, C.M., Macphee, C.E. and Welland, M.E. (2006) Characterization of the nanoscale properties of individual amyloid fibrils. Proc. Natl Acad. Sci. U.S.A. 103, 15806&#x2013;15811 10.1073/pnas.0604035103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0604035103</ArticleId><ArticleId IdType="pmc">PMC1635084</ArticleId><ArticleId IdType="pubmed">17038504</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles, T.P., Fitzpatrick, A.W., Meehan, S., Mott, H.R., Vendruscolo, M., Dobson, C.M.et al. (2007) Role of intermolecular forces in defining material properties of protein nanofibrils. Science 318, 1900&#x2013;1903 10.1126/science.1150057</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1150057</ArticleId><ArticleId IdType="pubmed">18096801</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul, T.J., Hoffmann, Z., Wang, C., Shanmugasundaram, M., DeJoannis, J., Shekhtman, A.et al. (2016) Structural and mechanical properties of amyloid beta fibrils: a combined experimental and theoretical approach. J. Phys. Chem. Lett. 7, 2758&#x2013;2764 10.1021/acs.jpclett.6b01066</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpclett.6b01066</ArticleId><ArticleId IdType="pmc">PMC5956519</ArticleId><ArticleId IdType="pubmed">27387853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamour, G., Nassar, R., Chan, P.H.W., Bozkurt, G., Li, J., Bui, J.M.et al. (2017) Mapping the broad structural and mechanical properties of amyloid fibrils. Biophys. J. 112, 584&#x2013;594 10.1016/j.bpj.2016.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.12.036</ArticleId><ArticleId IdType="pmc">PMC5340157</ArticleId><ArticleId IdType="pubmed">28256219</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon, G., Lee, M., Kim, K., Kim, J.I., Chang, H.J., Baek, I.et al. (2015) Morphology and mechanical properties of multi-stranded amyloid fibrils probed by atomistic and coarse-grained simulations. Phys. Biol. 12, 066021 10.1088/1478-3975/12/6/066021</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1478-3975/12/6/066021</ArticleId><ArticleId IdType="pubmed">26717468</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford Hill, A. (1965) Environment and disease: association or causation? Proc. R. Soc. Med. 58, 295&#x2013;300</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1898525</ArticleId><ArticleId IdType="pubmed">14283879</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanaroff, A.C., Garcia, S. and Giri, J. (2021) Myocardial infarction during the COVID-19 pandemic. JAMA 326, 1916&#x2013;1918 10.1001/jama.2021.19608</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.19608</ArticleId><ArticleId IdType="pubmed">34714324</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis, I., Fonseca-Rodr&#xed;guez, O., Farrington, P., Lindmark, K. and Fors Connolly, A.M. (2021) Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet 398, 599&#x2013;607 10.1016/S0140-6736(21)00896-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00896-5</ArticleId><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntaios, G., Michel, P., Georgiopoulos, G., Guo, Y., Li, W., Xiong, J.et al. (2020) Characteristics and outcomes in patients With COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry. Stroke 51, e254&#x2013;e258 10.1161/STROKEAHA.119.026907</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.119.026907</ArticleId><ArticleId IdType="pmc">PMC7359900</ArticleId><ArticleId IdType="pubmed">32787707</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry, R.J., Smith, C.J., Roffe, C., Simister, R., Narayanamoorthi, S., Marigold, R.et al. (2021) Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. J. Neurol. Neurosurg. Psychiatry 92, 242&#x2013;248 10.1136/jnnp-2020-324927</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324927</ArticleId><ArticleId IdType="pubmed">33154179</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe, B., Xie, Y., Xu, E. and Al-Aly, Z. (2021) Kidney outcomes in long COVID. J. Am. Soc. Nephrol. 32, 2851&#x2013;2862 10.1681/ASN.2021060734</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende, S. and Parikh, C.R. (2021) Long COVID and kidney disease. Nat. Rev. Nephrol. 17, 792&#x2013;793 10.1038/s41581-021-00487-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00487-3</ArticleId><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj, S.R., Arnold, A.C., Barboi, A., Claydon, V.E., Limberg, J.K., Lucci, V.M.et al. (2021) Long-COVID postural tachycardia syndrome: an American autonomic society statement. Clin. Auton. Res. 31, 365&#x2013;368 10.1007/s10286-021-00798-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard, J., Leth, S., Pedersen, T.H., Harbo, T., Blicher, J.U., Karlsson, P.et al. (2021) Myopathic changes in patients with long-term fatigue after COVID-19. Clin. Neurophysiol. 132, 1974&#x2013;1981 10.1016/j.clinph.2021.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.04.009</ArticleId><ArticleId IdType="pmc">PMC8102077</ArticleId><ArticleId IdType="pubmed">34020890</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares, M.N., Eggelbusch, M., Naddaf, E., Gerrits, K.H.L., van der Schaaf, M., van den Borst, B.et al. (2021) Skeletal muscle alterations in patients with acute COVID-19 and post-acute sequelae of COVID-19. J. Cachexia Sarcopenia Muscle 13, 11&#x2013;22 10.1002/jcsm.12896</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12896</ArticleId><ArticleId IdType="pmc">PMC8818659</ArticleId><ArticleId IdType="pubmed">34997689</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X.et al. (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 220&#x2013;232 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou, A.G., Jahaj, E., Ilias, I., Markaki, V., Malachias, S., Vrettou, C.et al. (2020) Lactate kinetics reflect organ dysfunction and Are associated with adverse outcomes in intensive care unit patients with COVID-19 pneumonia: preliminary results from a GREEK single-Centre study. Metabolites 10, 386 10.3390/metabo10100386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10100386</ArticleId><ArticleId IdType="pmc">PMC7599563</ArticleId><ArticleId IdType="pubmed">32998323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nechipurenko, Y.D., Semyonov, D.A., Lavrinenko, I.A., Lagutkin, D.A., Generalov, E.A., Zaitceva, A.Y.et al. (2021) The role of acidosis in the pathogenesis of severe forms of COVID-19. Biology (Basel) 10, 852 10.3390/biology10090852</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10090852</ArticleId><ArticleId IdType="pmc">PMC8469745</ArticleId><ArticleId IdType="pubmed">34571729</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts, I., Wright Muelas, M., Taylor, J.M., Davison, A.S., Xu, Y., Grixti, J.M.et al. (2022) Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics 18, 6 10.1007/s11306-021-01859-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-021-01859-3</ArticleId><ArticleId IdType="pmc">PMC8686810</ArticleId><ArticleId IdType="pubmed">34928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins, T., Gonevski, M., Clark, C., Baitule, S., Sharma, K., Magar, A.et al. (2021) Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin. Med. (Lond) 21, e629&#x2013;e632 10.7861/clinmed.2021-0462</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, G.F., Xu, T.H., Yan, Y., Zhou, Y.R., Jiang, Y., Melcher, K.et al. (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 38, 1205&#x2013;1235 10.1038/aps.2017.28</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.28</ArticleId><ArticleId IdType="pmc">PMC5589967</ArticleId><ArticleId IdType="pubmed">28713158</ArticleId></ArticleIdList></Reference><Reference><Citation>Drabik, D., Chodaczek, G. and Kraszewski, S. (2020) Effect of amyloid-beta monomers on lipid membrane mechanical parameters-Potential implications for mechanically driven neurodegeneration in Alzheimer's disease. Int. J. Mol. Sci. 22, 18 10.3390/ijms22010018</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010018</ArticleId><ArticleId IdType="pmc">PMC7792773</ArticleId><ArticleId IdType="pubmed">33375009</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanesi, L., Sheynis, T., Xue, W.F., Orlova, E.V., Hellewell, A.L., Jelinek, R.et al. (2012) Direct three-dimensional visualization of membrane disruption by amyloid fibrils. Proc. Natl Acad. Sci. U.S.A. 109, 20455&#x2013;20460 10.1073/pnas.1206325109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206325109</ArticleId><ArticleId IdType="pmc">PMC3528594</ArticleId><ArticleId IdType="pubmed">23184970</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco, G., Chen, S.W., Williamson, P.T.F., Cascella, R., Perni, M., Jarvis, J.A.et al. (2017) Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers. Science. 358, 1440&#x2013;1443 10.1126/science.aan6160</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan6160</ArticleId><ArticleId IdType="pubmed">29242346</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheckel, C. and Aguzzi, A. (2018) Prions, prionoids and protein misfolding disorders. Nat. Rev. Genet. 19, 405&#x2013;418 10.1038/s41576-018-0011-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-018-0011-4</ArticleId><ArticleId IdType="pubmed">29713012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Knowles, J.D. (2006) The role of modeling in systems biology. In System Modeling in Cellular Biology: From Concepts to Nuts and Bolts (Szallasi, Z., Stelling, J. and Periwal, V., eds). pp. 3&#x2013;18, MIT Press, Cambridge</Citation></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2018) No effects without causes. The iron dysregulation and dormant microbes hypothesis for chronic, inflammatory diseases. Biol. Rev. 93, 1518&#x2013;1557 10.1111/brv.12407</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12407</ArticleId><ArticleId IdType="pmc">PMC6055827</ArticleId><ArticleId IdType="pubmed">29575574</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein, S.R., Ramelli, S.C., Grazioli, A., Chung, J.-Y., Singh, M., Yinda, C.K.et al. (2021) SARS-CoV-2 infection and persistence throughout the human body and brain. Res. Square 10.21203/rs.3.rs-1139035/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1139035/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson, B.K., Francisco, E.B., Yogendra, R., Long, E., Pise, A., Rodrigues, H.et al. (2022) Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-Acute sequelae of COVID-19 (PASC) Up to 15 months post-Infection. Front. Immunol. 12, 746021 10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer, A., Rashid, T. and Wilson, C. (2010) Rheumatoid arthritis, proteus, anti-CCP antibodies and karl popper. Autoimmun. Rev. 9, 216&#x2013;223 10.1016/j.autrev.2009.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.10.006</ArticleId><ArticleId IdType="pubmed">19895906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer, A. (2012) Rheumatoid Arthritis and Proteus, Springer, London</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi, A.J. and Proenca, R.B. (2020) Akt-Fas to quell aberrant T cell differentiation and apoptosis in COVID-19. Front. Immunol. 11, 600405 10.3389/fimmu.2020.600405</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.600405</ArticleId><ArticleId IdType="pmc">PMC7779612</ArticleId><ArticleId IdType="pubmed">33408715</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff, M.C., Ramonell, R.P., Lee, F.E.-H. and Sanz, I. (2020) Clinically identifiable autoreactivity is common in severe SARS-CoV-2 infection. medRxiv 10.1101/2020.10.21.20216192</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.21.20216192</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh, C., Darley, D.R., Wilson, D.B., Howe, A., Munier, C.M.L., Patel, S.K.et al. (2022) Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210&#x2013;216 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntas, G., Mansell, T.J., Kim, J.R. and Ostermeier, M. (2005) Directed evolution of protein switches and their application to the creation of ligand-binding proteins. Proc. Natl Acad. Sci. U.S.A. 102, 11224&#x2013;11229 10.1073/pnas.0502673102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0502673102</ArticleId><ArticleId IdType="pmc">PMC1183557</ArticleId><ArticleId IdType="pubmed">16061816</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizcaychipi, M.P., Shovlin, C.L., McCarthy, A., Howard, A., Brown, A., Hayes, M.et al. (2020) Development and implementation of a COVID-19 near real-time traffic light system in an acute hospital setting. Emerg. Med. J. 37, 630&#x2013;636 10.1136/emermed-2020-210199</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2020-210199</ArticleId><ArticleId IdType="pubmed">32948623</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart, S., Newson, L., Briggs, T.A., Grammatopoulos, D., Young, L. and Gill, P. (2021) Long COVID risk - a signal to address sex hormones and women's health. Lancet Reg. Health Eur. 11, 100242 10.1016/j.lanepe.2021.100242</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanepoel, A.C., Lindeque, B.G., Swart, P.J., Abdool, Z. and Pretorius, E. (2014) Ultrastructural changes of fibrin networks during three phases of pregnancy: a qualitative investigation. Microsc. Res. Tech. 77, 602&#x2013;608 10.1002/jemt.22385</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.22385</ArticleId><ArticleId IdType="pubmed">24861478</ArticleId></ArticleIdList></Reference><Reference><Citation>Pipe, S.W., Kaczmarek, R., Srivastava, A., Pierce, G.F., Makris, M. and Hermans, C. and Interim Guidance Coagulation Products Safety Supply Access Committee of the World Federation of H. (2021) Management of COVID-19-associated coagulopathy in persons with haemophilia. Haemophilia 27, 41&#x2013;48 10.1111/hae.14191</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hae.14191</ArticleId><ArticleId IdType="pmc">PMC7753457</ArticleId><ArticleId IdType="pubmed">33216448</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Lipinski, B., Bester, J., Vermeulen, N. and Soma, P. (2013) Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes. Ultrastruct. Pathol. 37, 254&#x2013;257 10.3109/01913123.2013.778929</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913123.2013.778929</ArticleId><ArticleId IdType="pubmed">23672265</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Mbotwe, S. and Kell, D.B. (2017) Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular comorbidities. Sci. Rep. 7, 9680 10.1038/s41598-017-09860-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09860-4</ArticleId><ArticleId IdType="pmc">PMC5574907</ArticleId><ArticleId IdType="pubmed">28851981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper, G.J.S., Leighton, B., Dimitriadis, G.D., Parrybillings, M., Kowalchuk, J.M., Howland, K.et al. (1988) Amylin found in amyloid deposits in human type-2 diabetes-Mellitus May Be a hormone that regulates glycogen-Metabolism in skeletal-Muscle. Proc. Natl Acad. Sci. U.S.A. 85, 7763&#x2013;7766 10.1073/pnas.85.20.7763</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.20.7763</ArticleId><ArticleId IdType="pmc">PMC282273</ArticleId><ArticleId IdType="pubmed">3051005</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts, A.N., Leighton, B., Todd, J.A., Cockburn, D., Schofield, P.N., Sutton, R.et al. (1989) Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc. Natl Acad. Sci. U.S.A. 86, 9662&#x2013;9666 10.1073/pnas.86.24.9662</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.24.9662</ArticleId><ArticleId IdType="pmc">PMC298561</ArticleId><ArticleId IdType="pubmed">2690069</ArticleId></ArticleIdList></Reference><Reference><Citation>Konarkowska, B., Aitken, J.F., Kistler, J., Zhang, S. and Cooper, G.J.S. (2006) The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J. 273, 3614&#x2013;3624 10.1111/j.1742-4658.2006.05367.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2006.05367.x</ArticleId><ArticleId IdType="pubmed">16884500</ArticleId></ArticleIdList></Reference><Reference><Citation>Seet, R.C.S., Quek, A.M.L. and Lim, E.C.H. (2007) Post-infectious fatigue syndrome in dengue infection. J. Clin. Virol. 38, 1&#x2013;6 10.1016/j.jcv.2006.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.10.011</ArticleId><ArticleId IdType="pubmed">17137834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung, T.M., Wills, B., Clapham, H.E., Yacoub, S. and Turner, H.C. (2019) The uncertainty surrounding the burden of post-acute consequences of dengue infection. Trends Parasitol. 35, 673&#x2013;676 10.1016/j.pt.2019.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pt.2019.06.004</ArticleId><ArticleId IdType="pubmed">31279656</ArticleId></ArticleIdList></Reference><Reference><Citation>Umakanth, M. (2018) Post dengue fatigue syndrome (PDFS) among dengue IgM-Antibody positive patients at batticaloa teaching hospital, Sri Lanka. Open Acc. Lib. J. 5, e4798 10.4236/oalib.1104798</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/oalib.1104798</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond, N.G., Grant, D.S., Himmelfarb, S.T., Engel, E.J., Al-Hasan, F., Gbakie, M.et al. (2021) Post-Ebola syndrome presents With multiple overlapping symptom clusters: evidence from an ongoing cohort study in eastern Sierra Leone. Clin. Infect. Dis. 73, 1046&#x2013;1054 10.1093/cid/ciab267</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab267</ArticleId><ArticleId IdType="pmc">PMC8442780</ArticleId><ArticleId IdType="pubmed">33822010</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki, T.K. (2016) Post-Ebola syndrome. Lancet Infect. Dis. 16, 780&#x2013;781 10.1016/S1473-3099(15)00259-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00259-5</ArticleId><ArticleId IdType="pubmed">27352759</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott, J.T., Sesay, F.R., Massaquoi, T.A., Idriss, B.R., Sahr, F. and Semple, M.G. (2016) Post-Ebola syndrome, Sierra Leone. Emerg. Infect. Dis. 22, 641&#x2013;646 10.3201/eid2204.151302</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2204.151302</ArticleId><ArticleId IdType="pmc">PMC4806950</ArticleId><ArticleId IdType="pubmed">26983037</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebman, A.W. and Aucott, J.N. (2020) Post-treatment lyme disease as a model for persistent symptoms in lyme disease. Front. Med. (Lausanne) 7, 57 10.3389/fmed.2020.00057</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00057</ArticleId><ArticleId IdType="pmc">PMC7052487</ArticleId><ArticleId IdType="pubmed">32161761</ArticleId></ArticleIdList></Reference><Reference><Citation>Potgieter, M., Bester, J., Kell, D.B. and Pretorius, E. (2015) The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol. Rev. 39, 567&#x2013;591 10.1093/femsre/fuv013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuv013</ArticleId><ArticleId IdType="pmc">PMC4487407</ArticleId><ArticleId IdType="pubmed">25940667</ArticleId></ArticleIdList></Reference><Reference><Citation>Bots, M.L., Breteler, M.M., van Kooten, F., Haverkate, F., Meijer, P., Koudstaal, P.J.et al. (1998) Coagulation and fibrinolysis markers and risk of dementia. The Dutch vascular factors in dementia study. Haemostasis 28, 216&#x2013;222</Citation><ArticleIdList><ArticleId IdType="pubmed">10420069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes-Canteli, M., Paul, J., Norris, E.H., Bronstein, R., Ahn, H.J., Zamolodchikov, D.et al. (2010) Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron 66, 695&#x2013;709 10.1016/j.neuron.2010.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.05.014</ArticleId><ArticleId IdType="pmc">PMC2895773</ArticleId><ArticleId IdType="pubmed">20547128</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, T.L. and Weitzer, D.J. (2021) Long COVID and myalgic encephalomyelitis/Chronic fatigue syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 57, 418 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg, D., Berg, L.H., Couvaras, J. and Harrison, H. (1999) Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis. Blood Coagul. Fibrinol. 10, 435&#x2013;438 10.1097/00001721-199910000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-199910000-00006</ArticleId><ArticleId IdType="pubmed">10695770</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan, K.L., Berg, D.E., Baumzweiger, W., Harrison, H.H., Berg, L.H., Ramirez, R.et al. (2000) Activation of the coagulation system in gulf War illness: a potential pathophysiologic link with chronic fatigue syndrome. A laboratory approach to diagnosis. Blood Coagul. Fibrinol. 11, 673&#x2013;678 10.1097/00001721-200010000-00013</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-200010000-00013</ArticleId><ArticleId IdType="pubmed">11085289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Venter, C., Laubsher, G.J., Kotze, M.J., Moremi, K., Oladejo, S.et al. (2021) Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with long COVID/Post-Acute sequelae of COVID-19 (PASC) can resolve their persistent symptoms. Res. Square 10.21203/rs.3.rs-1205453/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1205453/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett, T.J., Cornwell, M., Myndzar, K., Rolling, C.C., Xia, Y., Drenkova, K.et al. (2021) Platelets amplify endotheliopathy in COVID-19. Sci. Adv. 7, eabh2434 10.1126/sciadv.abh2434</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh2434</ArticleId><ArticleId IdType="pmc">PMC8442885</ArticleId><ArticleId IdType="pubmed">34516880</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett, T.J., Bilaloglu, S., Cornwell, M., Burgess, H.M., Virginio, V.W., Drenkova, K.et al. (2021) Platelets contribute to disease severity in COVID-19. J. Thromb. Haemost. 19, 3139&#x2013;3153 10.1111/jth.15534</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15534</ArticleId><ArticleId IdType="pmc">PMC8646651</ArticleId><ArticleId IdType="pubmed">34538015</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikawa, M., Kanno, H., Zhou, Y., Xiao, T.H., Suzuki, T., Ibayashi, Y.et al. (2021) Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19. Nat. Commun. 12, 7135 10.1038/s41467-021-27378-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27378-2</ArticleId><ArticleId IdType="pmc">PMC8660840</ArticleId><ArticleId IdType="pubmed">34887400</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S., Liu, Y., Wang, X., Yang, L., Li, H., Wang, Y.et al. (2020) SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 13, 120 10.1186/s13045-020-00954-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, J.C. (2018) Disseminated intravascular coagulation: is it fact or fancy? Blood Coagul. Fibrinolysis 29, 330&#x2013;337 10.1097/MBC.0000000000000727</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000727</ArticleId><ArticleId IdType="pubmed">29621007</ArticleId></ArticleIdList></Reference><Reference><Citation>Perricone, C., Bartoloni, E., Bursi, R., Cafaro, G., Guidelli, G.M., Shoenfeld, Y.et al. (2020) COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol. Res. 68, 213&#x2013;224 10.1007/s12026-020-09145-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-020-09145-5</ArticleId><ArticleId IdType="pmc">PMC7366458</ArticleId><ArticleId IdType="pubmed">32681497</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Vargas, M. and Cort&#xe9;s-Rojo, C. (2020) Ferritin levels and COVID-19. Rev. Panam. Salud. Publica 44, e72 10.26633/RPSP.2020.72</Citation><ArticleIdList><ArticleId IdType="doi">10.26633/RPSP.2020.72</ArticleId><ArticleId IdType="pmc">PMC7286435</ArticleId><ArticleId IdType="pubmed">32547616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2014) Serum ferritin is an important disease marker, and is mainly a leakage product from damaged cells. Metallomics 6, 748&#x2013;773 10.1039/C3MT00347G</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C3MT00347G</ArticleId><ArticleId IdType="pubmed">24549403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. (2009) Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genom. 2, 2 10.1186/1755-8794-2-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-2-2</ArticleId><ArticleId IdType="pmc">PMC2672098</ArticleId><ArticleId IdType="pubmed">19133145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. (2010) Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 577, 825&#x2013;889 10.1007/s00204-010-0577-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-010-0577-x</ArticleId><ArticleId IdType="pmc">PMC2988997</ArticleId><ArticleId IdType="pubmed">20967426</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi, A., Troiani, E. and Corrao, S. (2020) COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin. Pract. 10, 1271 10.4081/cp.2020.1271</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Edeas, M., Saleh, J. and Peyssonnaux, C. (2020) Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis? Int. J. Infect. Dis. 97, 303&#x2013;305 10.1016/j.ijid.2020.05.110</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.110</ArticleId><ArticleId IdType="pmc">PMC7264936</ArticleId><ArticleId IdType="pubmed">32497811</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin, K.-M., Bechtel, M., Bojkova, D., M&#xfc;nch, C., Ciesek, S., Wass, M.N.et al. (2020) COVID-19-Related coagulopathy&#x2014;Is transferrin a missing link? Diagnostics 10, 539 10.3390/diagnostics10080539</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics10080539</ArticleId><ArticleId IdType="pmc">PMC7459734</ArticleId><ArticleId IdType="pubmed">32751741</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakurkar, V., Rajapurkar, M., Lele, S., Mukhopadhyay, B., Lobo, V., Injarapu, R.et al. (2021) Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19. Sci. Rep. 11, 19618 10.1038/s41598-021-99142-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99142-x</ArticleId><ArticleId IdType="pmc">PMC8490366</ArticleId><ArticleId IdType="pubmed">34608227</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, W. and Li, H. (2022) COVID-19: attacks the 1-beta chain of hemoglobin to disrupt respiratory function and escape immunity. chemRxiv 10.26434/chemrxiv-2021-dtpv3-v</Citation><ArticleIdList><ArticleId IdType="doi">10.26434/chemrxiv-2021-dtpv3-v</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione, E., Cosio, T., Rosa, L., Lanna, C., Di Girolamo, S., Gaziano, R.et al. (2020) Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. Int. J. Mol. Sci. 21, 4903 10.3390/ijms21144903</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21144903</ArticleId><ArticleId IdType="pmc">PMC7402319</ArticleId><ArticleId IdType="pubmed">32664543</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M.P., Iacovelli, F.et al. (2020) Pleiotropic effect of Lactoferrin in the prevention and treatment of COVID-19 infection: in vivo, in silico and in vitro preliminary evidences. bioRxiv 2020.08.11.244996 10.1101/2020.08.11.244996</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.11.244996</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga, M., Karampela, I. and Mantzoros, C.S. (2020) Commentary: could iron chelators prove to be useful as an adjunct to COVID-19 treatment regimens? Metabolism 108, 154260 10.1016/j.metabol.2020.154260</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154260</ArticleId><ArticleId IdType="pmc">PMC7207125</ArticleId><ArticleId IdType="pubmed">32418885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B., Heyden, E.L. and Pretorius, E. (2020) The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria. Front. Immunol. 11, 1221 10.3389/fimmu.2020.01221</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01221</ArticleId><ArticleId IdType="pmc">PMC7271924</ArticleId><ArticleId IdType="pubmed">32574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Abobaker, A. (2020) Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome? Eur. J. Clin. Pharmacol. 76, 1619&#x2013;1620 10.1007/s00228-020-02942-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-020-02942-9</ArticleId><ArticleId IdType="pmc">PMC7325475</ArticleId><ArticleId IdType="pubmed">32607779</ArticleId></ArticleIdList></Reference><Reference><Citation>Carota, G., Ronsisvalle, S., Panarello, F., Tibullo, D., Nicolosi, A. and Li Volti, G. (2021) Role of iron chelation and protease inhibition of natural products on COVID-19 infection. J. Clin. Med. 10, 2306 10.3390/jcm10112306</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112306</ArticleId><ArticleId IdType="pmc">PMC8198259</ArticleId><ArticleId IdType="pubmed">34070628</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseef, P.P., Elayadeth-Meethal, M., Salim, K.T.M., Anjana, A., Muhas, C., Vajid, K.A.et al. (2022) Therapeutic potential of induced iron depletion using iron chelators in COVID-19. Saudi J. Biol. Sci. 10.1016/j.sjbs.2021.11.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2021.11.061</ArticleId><ArticleId IdType="pmc">PMC8666385</ArticleId><ArticleId IdType="pubmed">34924800</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlahakos, V.D., Marathias, K.P., Arkadopoulos, N. and Vlahakos, D.V. (2021) Hyperferritinemia in patients with COVID-19: an opportunity for iron chelation? Artif. Organs. 45, 163&#x2013;167 10.1111/aor.13812</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.13812</ArticleId><ArticleId IdType="pubmed">32882061</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E.et al. (2021) Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 19, 2546&#x2013;2553 10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua, G., Pine, A.B., Meizlish, M.L., Chang, C.H., Zhang, H., Bahel, P.et al. (2020) Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 7, e575&#x2013;e582 10.1016/S2352-3026(20)30216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Shovlin, C.L. and Vizcaychipi, M.P. (2020) Vascular inflammation and endothelial injury in SARS-CoV-2 infection: the overlooked regulatory cascades implicated by the ACE2 gene cluster. QJM 10.1093/qjmed/hcaa241</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa241</ArticleId><ArticleId IdType="pmc">PMC7454888</ArticleId><ArticleId IdType="pubmed">32777054</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremmel, T., Frelinger, III, A.L. and Michelson, A.D. (2016) Platelet physiology. Semin Thromb Hemost. 42, 191&#x2013;204 10.1055/s-0035-1564835</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1564835</ArticleId><ArticleId IdType="pubmed">26926581</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M.J. and Pretorius, E. (2020) A champion of host defense: a generic large-Scale cause for platelet dysfunction and depletion in infection. Semin. Thromb. Hemost. 46, 302&#x2013;319 10.1055/s-0040-1708827</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1708827</ArticleId><ArticleId IdType="pmc">PMC7339151</ArticleId><ArticleId IdType="pubmed">32279287</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein, D.A. and Yin, W. (2018) Platelet-Activation mechanisms and vascular remodeling. Compr. Physiol. 8, 1117&#x2013;1156 10.1002/cphy.c170049</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c170049</ArticleId><ArticleId IdType="pubmed">29978900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J., Hajizadeh, N., Moore, E.E., McIntyre, R.C., Moore, P.K., Veress, L.A.et al. (2020) Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J. Thromb. Haemost. 18, 1752&#x2013;1755 10.1111/jth.14828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14828</ArticleId><ArticleId IdType="pmc">PMC7262152</ArticleId><ArticleId IdType="pubmed">32267998</ArticleId></ArticleIdList></Reference><Reference><Citation>ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, Lawler, P.R., Goligher, E.C., Berger, J.S.et al. (2021) Therapeutic anticoagulation with heparin in noncritically Ill patients with COVID-19. N. Engl. J. Med. 385, 790&#x2013;802 10.1056/NEJMoa2105911</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105911</ArticleId><ArticleId IdType="pmc">PMC8362594</ArticleId><ArticleId IdType="pubmed">34351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Mycroft-West, C.J., Su, D., Pagani, I., Rudd, T.R., Elli, S., Gandhi, N.S.et al. (2020) Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-Binding domain with heparin. Thromb. Haemost. 120, 1700&#x2013;1715 10.1055/s-0040-1721319</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1721319</ArticleId><ArticleId IdType="pmc">PMC7869224</ArticleId><ArticleId IdType="pubmed">33368089</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandon, R., Sharp, J.S., Zhang, F., Pomin, V.H., Ashpole, N.M., Mitra, D.et al. (2021) Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin derivatives. J. Virol. 95, e01987-20 10.1128/JVI.01987-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01987-20</ArticleId><ArticleId IdType="pmc">PMC7925120</ArticleId><ArticleId IdType="pubmed">33173010</ArticleId></ArticleIdList></Reference><Reference><Citation>Tree, J.A., Turnbull, J.E., Buttigieg, K.R., Elmore, M.J., Coombes, N., Hogwood, J.et al. (2021) Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. Br. J. Pharmacol. 178, 626&#x2013;635 10.1111/bph.15304</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15304</ArticleId><ArticleId IdType="pmc">PMC9328389</ArticleId><ArticleId IdType="pubmed">33125711</ArticleId></ArticleIdList></Reference><Reference><Citation>Paiardi, G., Richter, S., Oreste, P., Urbinati, C., Rusnati, M. and Wade, R.C. (2022) The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms. J. Biol. Chem. 298, 101507 10.1016/j.jbc.2021.101507</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101507</ArticleId><ArticleId IdType="pmc">PMC8683219</ArticleId><ArticleId IdType="pubmed">34929169</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes, R.D., de Barros, E.S.P.G.M., Furtado, R.H.M., Macedo, A.V.S., Bronhara, B., Damiani, L.P.et al. (2021) Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet 397, 2253&#x2013;2263 10.1016/S0140-6736(21)01203-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01203-4</ArticleId><ArticleId IdType="pmc">PMC8177770</ArticleId><ArticleId IdType="pubmed">34097856</ArticleId></ArticleIdList></Reference><Reference><Citation>Viecca, M., Radovanovic, D., Forleo, G.B. and Santus, P. (2020) Enhanced platelet inhibition treatment improves hypoxemia in patients with severe COVID-19 and hypercoagulability. A case control, proof of concept study. Pharmacol. Res. 158, 104950 10.1016/j.phrs.2020.104950</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104950</ArticleId><ArticleId IdType="pmc">PMC7244436</ArticleId><ArticleId IdType="pubmed">32450344</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Togt, V., McFarland, S., Esperti, M., Semper, E., Citrenbaum, S. and Rossman, J.S. (2021) Promotion of non-evidence-based therapeutics within patient-led long COVID support groups. Nat. Med. 27, 2068&#x2013;2069 10.1038/s41591-021-01589-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01589-y</ArticleId><ArticleId IdType="pubmed">34893773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozie&#x142;, M., Potpara, T.S. and Lip, G.Y.H. (2020) Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting. Res. Pract. Thromb. Haemost. 4, 357&#x2013;365 10.1002/rth2.12319</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12319</ArticleId><ArticleId IdType="pmc">PMC7086461</ArticleId><ArticleId IdType="pubmed">32211570</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Venter, C., Laubscher, G.J., Lourens, P.J., Steenkamp, J. and Kell, D.B. (2020) Prevalence of readily detected amyloid blood clots in &#x2018;unclotted&#x2019; type 2 diabetes mellitus and COVID-19 plasma: a preliminary report. Cardiovasc. Diabetol. 19, 193 10.1186/s12933-020-01165-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Thagard, P. (2007) Coherence, truth, and the development of scientific knowledge. Philos. Sci. 74, 28&#x2013;47 10.1086/520941</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520941</ArticleId></ArticleIdList></Reference><Reference><Citation>Thagard, P. (2008) Explanatory Coherence. Reasoning: Studies of Human Inference and Its Foundations, 471&#x2013;513</Citation></Reference><Reference><Citation>Bradford Hill, A. and Hill, I.D. (1991) Bradford Hill's Principles of Medical Statistics, Edward Arnold, London</Citation></Reference><Reference><Citation>Schaffner, K.F. (1993) Discovery and Explanation in Biology and Medicine, University of Chicago Press, Chicago</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>